Final answer:
Pharmacies that compound sterile products (except hospital pharmacies that compound sterile products for inpatients) must report adverse drug experiences and events on a quarterly basis.
Step-by-step explanation:
Pharmacies that compound sterile products (except hospital pharmacies that compound sterile products for inpatients) are required to report certain information to the board on a quarterly basis. This information includes adverse drug experiences and events. Specifically, they must report unexpected serious and fatal adverse drug events within 15 days, and other events on a quarterly basis. These reports are important for monitoring and ensuring the safety and effectiveness of compounded sterile products.